CUBICIN

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug CUBICIN contains one active pharmaceutical ingredient (API):

1 Daptomycin UNII NWQ5N31VKK - DAPTOMYCIN

Daptomycin is a cyclic lipopeptide natural product that is active against Gram positive bacteria only. The mechanism of action involves binding to bacterial membranes of both growing and stationary phase cells causing depolarisation and leading to a rapid inhibition of protein, DNA, and RNA synthesis. Read about Daptomycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CUBICIN Powder for concentrate for solution for injection or infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XX09	Daptomycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525517100020117, 525517100020217
Country: CA	Health Products and Food Branch	Identifier(s): 02465493
Country: EE	Ravimiamet	Identifier(s): 1257779, 1257780, 1492938, 1492949
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 05328001, 05328002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 061961, 061970
Country: FR	Base de données publique des médicaments	Identifier(s): 62442395, 69811090
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 101402, 109616
Country: HK	Department of Health Drug Office	Identifier(s): 57551
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7073
Country: JP	医薬品医療機器総合機構	Identifier(s): 6119402D1021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028352, 1028353, 1063651, 1063652
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 90883
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13186
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100165318, 100165324
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64829001, W64829002, W64830001, W64830002
Country: SG	Health Sciences Authority	Identifier(s): 13501P
Country: US	FDA, National Drug Code	Identifier(s): 67919-011, 67919-012
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/20.1/0954